Macrophage Therapeutics
Macrophage Therapeutics (MT) is developing novel immuno-oncology and targeted anti-inflammatory therapeutics based on its proprietary Activated Macrophage targeting platform. MT is leveraging its unique CD206 receptor-based delivery system to deliver proven therapeutics in a more precise and targeted fashion. With binding affinities 10,000X today’s best antibodies MT’s approach eliminates off-target toxicity and increases the efficacy of proven therapeutic agents. MT’s CD206 targeting platform is already clinically established and being used in an FDA/EMEA approved radiopharmaceutical.
Domain
macrophagetherapeutics.com
Country
United StatesIndustry
OncologyEmployees
1-10
Last Funding
$2.5M
Founded
2014
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Macrophage Therapeutics use?+
Macrophage Therapeutics uses 11 technologies including Odoo, Backdrop, Popper.
What industry is Macrophage Therapeutics in?+
Macrophage Therapeutics operates in the Oncology industry.
Where is Macrophage Therapeutics based?+
Macrophage Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026